日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Melanin-Driven Delayed CPD Formation Is Independent of Melanin Biosynthesis Pathway

黑色素驱动的延迟CPD形成与黑色素生物合成途径无关

Yadav, Vipin K; Srivastava, Jyoti; Venkatachalam, Avanthika; Tantak, Mukund P; Lawrence, Nicholas J; Fisher, David E; Lawrence, Harshani R; Premi, Sanjay

Identification of MITF-regulated transcript isoforms of ubiquitously expressed genes

鉴定普遍表达基因的MITF调控转录本异构体

Ostrowski, Stephen M; Klibaner-Schiff, Eleanor; Zhang, John Ming; Hamlin, Erin; Ebrahimi, Kiran; Boozer, Judith R; Kaminiow, Konrad; Fisher, David E

A Rating Scale for Obtaining Specific, Actionable Evaluations of Nasolabial Aesthetics after Unilateral Cleft Lip Repair

用于对单侧唇裂修复术后鼻唇沟美观进行具体、可操作评估的评分量表

Sitzman, Thomas J; Samson, Thomas D; Tse, Raymond W; Matic, Damir B; Fisher, David M; Beals, Stephen P; Allori, Alexander C; Marcus, Jeffrey R; Bezuhly, Michael; Hanna, Helena

A novel approach to target skin photodamage: Topical application of salt inducible kinase inhibitors

一种治疗皮肤光损伤的新方法:局部应用盐诱导激酶抑制剂

Rachmin, Inbal; Le Varlet, Béatrice; Regazzetti, Claire; Passeron, Thierry; Wang, Jinhua; Fisher, David E; Schaison, Philippe; Shroot, Braham

Marty's last publication: A giant human being with a passion to cure children

马蒂的最后一篇出版物:《一个热衷于治愈儿童的巨人》。

Fisher, David E

Ipilimumab with and without nivolumab in patients with classic Hodgkin lymphoma with progression after PD-1 blockade

伊匹木单抗联合或不联合纳武利尤单抗治疗PD-1阻断后进展的经典霍奇金淋巴瘤患者

Merryman, Reid W; Kline, Justin; Redd, Robert A; Olszewski, Harrison; Welsh, Emma; Pfaff, Kathleen; Lee, Hannah; McDonough, Mikaela; Ahn, Inhye E; Brown, Jennifer R; Crombie, Jennifer L; Davids, Matthew S; Fisher, David C; Jacobsen, Eric D; Jacobson, Caron A; Kim, Austin I; Odejide, Oreofe O; Parry, Erin Michelle; Ryan, Christine E; Shipp, Margaret A; Armand, Philippe; Rodig, Scott; Abramson, Jeremy S; LaCasce, Ann S

Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma

Denileukin Diftitox-Cxdl(一种纯度更高的 Denileukin Diftitox 制剂)在复发或难治性皮肤 T 细胞淋巴瘤患者中的疗效和安全性

Foss, Francine M; Kim, Youn H; Prince, H Miles; Akilov, Oleg E; Querfeld, Christiane; Seminario-Vidal, Lucia; Fisher, David C; Kuzel, Timothy M; Yannakou, Costas K; Geskin, Larisa J; Feldman, Tatyana; Sokol, Lubomir; Allen, Pamela Blair; Dang, Nam Hoang; Cabanillas, Fernando; Wong, Henry K; Ooi, Chean Eng; Xing, Dongyuan; Sauter, Nicholas; Singh, Preeti; Czuczman, Myron; Duvic, Madeleine

Phase II Study of Acalabrutinib, Venetoclax, and Obinutuzumab in a Treatment-Naïve Chronic Lymphocytic Leukemia Population Enriched for High-Risk Disease

在富含高危疾病的初治慢性淋巴细胞白血病患者人群中开展的阿卡替尼、维奈克拉和奥妥珠单抗的II期研究

Davids, Matthew S; Ryan, Christine E; Lampson, Benjamin L; Ren, Yue; Tyekucheva, Svitlana; Fernandes, Stacey M; Crombie, Jennifer L; Kim, Austin I; Weinstock, Matthew; Montegaard, Josie; Walker, Heather A; Greenman, Claire; Patterson, Victoria; Jacobson, Caron A; LaCasce, Ann S; Armand, Philippe; Fisher, David C; Lo, Steve; Olszewski, Adam J; Arnason, Jon E; Ahn, Inhye E; Brown, Jennifer R

Long-term results of a phase 1/1b study of ibrutinib plus umbralisib for relapsed/refractory chronic lymphocytic leukemia

伊布替尼联合乌布拉利西治疗复发/难治性慢性淋巴细胞白血病的1/1b期研究的长期结果

Ryan, Christine E; Ren, Yue; Tyekucheva, Svitlana; Arnason, Jon E; Boruchov, Adam M; Jacobson, Caron A; Fisher, David C; Miskin, Hari; Sportelli, Peter; Brown, Jennifer R; Davids, Matthew S

Type 2 immunity links eczematous and lichenoid eruptions caused by immune checkpoint inhibitors.

2 型免疫与免疫检查点抑制剂引起的湿疹样皮疹和苔藓样皮疹有关。

Azin Marjan, Farokh Parisa, McGarry Alexander, Leung Bonnie W, Roster Kathleen, Rashdan Hannah, Rajeh Ahmad, Khattab Sara, Stephens Michael R, Thang Christopher Jayee, Fisher David E, Nazarian Rosalynn M, Chen Steven T, Semenov Yevgeniy R, Demehri Shadmehr